Related Experiment Video
Updated: Oct 3, 2026

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
Published on: May 14, 2012
Lymphocyte transformation induced by autologous splenocytes incorporated with the tetrasialoganglioside GQ1b
Incorporation of the tetrasialoganglioside GQ1b into membranes of mouse splenocytes rendered these cells effective triggers in an autologous mixed lymphocyte reaction. Whereas GQ1b-incorporated cells increased mitogenic responses of thymocytes by 10 to 13-fold over untreated cultures, the trisialoganglioside GT1b was only partially effective, and the di- and monosialogangliosides tested had no effect. The mixed lymphocyte reaction generated in the autologous system by highly glycosylated gangliosides is abolished by neuraminidase or mile formic acid treatment prior to their insertion into target cell membranes suggesting a role for the extra sialic acid residues in imparting additional antigenic specificity to the modified cells.
Incorporation of the tetrasialoganglioside GQ1b into membranes of mouse splenocytes rendered these cells effective triggers in an autologous mixed lymphocyte reaction. Whereas GQ1b-incorporated cells increased mitogenic responses of thymocytes by 10 to 13-fold over untreated cultures, the trisialoganglioside GT1b was only partially effective, and the di- and monosialogangliosides tested had no effect. The mixed lymphocyte reaction generated in the autologous system by highly glycosylated gangliosides is abolished by neuraminidase or mile formic acid treatment prior to their insertion into target cell membranes suggesting a role for the extra sialic acid residues in imparting additional antigenic specificity to the modified cells.
More Related Videos
10:00Preparation of CD4+ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy
Published on: November 8, 2016
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018